Dr. James Matthew Mobley, MD

In 2023, among providers in related specialties within Arkansas, Dr. James Matthew Mobley, MD performed more white blood cell (WBC) differential procedures for Medicare patients than 95% of them and he also had a list price for therapeutic phlebotomy that was lower than the list prices billed to Medicare by 95% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

In 2023, Dr. James Matthew Mobley, MD had a list price for iron tests, lactate dehydrogenase (LDH) test, magnesium test, uric acid blood test, and uric acid test that was lower than the list prices billed to Medicare by 90% of providers in related specialties within Arkansas. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

In 2013, among providers in related specialties within Arkansas, Dr. James Matthew Mobley, MD performed more biological response modifier (BRM) therapy, inpatient hospital care (for patient admitted to hospital), intravenous (IV) chemotherapy, intravenous (IV) infusion, phosphorus blood test, and port flush procedures for Medicare patients than 75% of them and he also had a list price for antineoplastic hormone therapy, blood count tests, blood tests, chest CT scan, complete blood count (CBC), hormone therapy, lab tests, liver function tests (LFTs), phosphorus blood test, phosphorus test, and thoracic (chest) imaging that was lower than the list prices billed to Medicare by 75% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.